The Middle East & Africa pen needles market size is expected to reach USD 0.48 billion by 2027 from USD 0.29 billion in 2022, growing at a CAGR of 10.77% for the next five years, 2022 to 2027.
Pen needles are used to deliver the medication (such as insulin or other injectable medications) combined with injection pens. A pen needle comprises a hollow needle attached to an injection pen. Pen needles are available with varied needle lengths and are majorly utilized by diabetes patients.
Growing annual health care expenditure, increasing public & private organizations' involvement in diabetes awareness programs, and rising demand for advanced insulin delivery devices drive the growth of the Middle East & Africa pen needles market. However, limited accessibility of pen needles and lack of health care infrastructure & outdated facilities are restraining the growth of the Middle East & Africa pen needles market.
This research report on the Middle East and Africa Pen Needles Market has been segmented and sub-segmented into the following categories:
By Therapy:
By Type:
By Needle Length:
By Mode of Purchase:
By Country:
Companies leading the MEA Pen Needles Market profiled in this report are Becton Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), Owen Mumford, Ltd. (U.K.), B. Braun Melsungen (Germany), Artsana S.p.a. (Italy), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan) and others.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com